Earningsreport

Q1/2026 3/31/2026 EPS -0.330 ZacksConsensus -0.330 ActVsEst 0.000 - In-Line

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations